Robert O'Keeffe

Rob Graduated with BEng (Hons) Chemical Engineering Degree from University College Dublin in 2010 and MSc in Biopharmaceutical Science in 2013. He joined Eli Lilly in 2010 specializing in Bioprocess Design, Facility Design and Start-up, Facility Fit Modelling, and more recently Next Generation Bioprocessing. He has worked on the design, start-up, and validation of four of Lilly’s commercial mAb facilities and was also the lead process engineer for Lilly’s Covid Mab Tech Transfers globally. He is currently finishing a part-time PhD with University College Dublin on Bioprocess Modelling and Next Generation Bioprocessing.